Original Article

Effects of Preoperative COVID-19 Status on Emergent or Urgent Colectomy Outcomes

Authors: Satyam K. Ghodasara, BS, Grace C. Chang, DO, Justin S. Roskam, BS, Sara S. Soliman, BS, Kaitlyn Oldewurtel, DO, Rolando H. Rolandelli, MD, Zoltan H. Nemeth, MD, PhD

Abstract

Objectives: Severe acute respiratory syndrome coronavirus 2 has been described as eliciting a powerful immune response. The association of coronavirus disease 2019 (COVID-19) infection with diseases requiring emergent or urgent colectomies may exacerbate the risk of surgical complications. We investigated the effect of preoperative COVID-19 infection on the clinical outcomes of patients who underwent a nonelective colectomy in 2021.

Methods: We queried the American College of Surgeons National Surgical Quality Improvement Program Targeted Colectomy database for all of the patients who underwent a colectomy in 2021 and filtered for patients classified as “Urgent” or “Emergent.” Two groups were created based on preoperative COVID-19 status: COVID+ (n = 242) and COVID− cohorts (n = 11,049). Several clinical variables were compared.

Results: Before filtering for urgent/emergent operations, a large percentage of COVID+ patients were found to have undergone an urgent or emergency colectomy (68.36% vs 25.05%). Preoperatively, these patients were more likely to be taking steroids (21.49% vs 12.41%) or have a bleeding issue requiring a transfusion (19.42% vs 11.00%). A larger percentage of infected patients returned to the operating room (14.05% vs 8.13%) and had a hospital stay >30 days (18.18% vs 5.35%). COVID-19 infection was associated with a higher rate of mortality (14.05% vs 8.08%) but did not independently predict it (odds ratio 1.25, P = 0.233), with all P ≤ 0.001.

Conclusions: Urgent or emergent colectomy patients who were COVID-19+ preoperatively were more likely to present with comorbidities, which, along with the recent viral infection, contributed to markedly worse clinical outcomes, including an increased rate of mortality.
Posted in: Infectious Disease138

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Eijk LE, Binkhorst M, Bourgonje AR, et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol 2021;254: 307–331.
 
2. Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res 2020;226:57–69.
 
3. Wexner SD, Nelson H, Stain SC, et al. The American College of Surgeons response to the COVID-19 pandemic (part I): cancer care, COVID-19 registry, surgeon wellness. Am Surg 2020;86:751–756.
 
4. Tao SS, Wang XY, Yang XK, et al. COVID-19 and inflammatory bowel disease crosstalk: from emerging association to clinical proposal. J Med Virol 2022;94:5640–5652.
 
5. Leung WK, To K-F, Chan PKS, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003;125:1011–1017.
 
6. Haffner MR, Le HV, Saiz AM Jr, et al. Postoperative in-hospital morbidity and mortality of patients with COVID-19 infection compared with patients without COVID-19 infection. JAMA Netw Open 2021;4:e215697.
 
7. Deng JZ, Chan JS, Potter AL, et al. The risk of postoperative complications after major elective surgery in active or resolved COVID-19 in the United States. Ann Surg 2022;275:242–246.
 
8. Patel VK, Shirbhate E, Patel P, et al. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent. Beni Suef Univ J Basic Appl Sci 2021;10:78.
 
9. Anstead GM. Steroids, retinoids, and wound healing. Adv Wound Care 1998; 11:277–85.
 
10. Iba T, Levy JH, Connors JM, et al. The unique characteristics of COVID-19 coagulopathy. Crit Care 2020;24:360.
 
11. Whiteley W, Wood A. Risk of arterial and venous thromboses after COVID19. Lancet Infect Dis 2022;22:1093–1094.
 
12. Sakr Y, Giovini M, Leone M, et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care 2020;10:124.
 
13. Tan BK, Mainbourg S, Friggeri A, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax 2021;76:970–979.
 
14. Ospina-Tascón GA, Calderón-Tapia LE, García AF, et al. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA 2021;326:2161–2171.
 
15. Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 2020;10:783–791.
 
16. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2023;21:855.
 
17. Chang J, Assouline E, Calugaru K, et al. Minimally invasive colectomies can be performed with similar outcomes to open counterparts for colorectal cancer emergencies: a propensity score matching analysis utilizing ACSNSQIP. Tech Coloproctol 2023;27:1065–1071.
 
18. Pisano M, Zorcolo L, Merli C, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. World J Emerg Surg 2018;13:36.
 
19. Vallance AE, Keller DS, Hill J, et al. Role of emergency laparoscopic colectomy for colorectal cancer: a population-based study in England. Ann Surg 2019;270:172–179.
 
20. Zhu B, Feng X, Jiang C, et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study. BMC Infect Dis 2021;21:574.
 
21. Moghimi N, Bojesen RD, Rütz K. Paralytic ileus as an extra-pulmonary manifestation of COVID-19. Cureus 2023;15:e35480.
 
22. Kaafarani HMA, El Moheb M, Hwabejire JO, et al. Gastrointestinal complications in critically ill patients with COVID-19. Ann Surg 2020;272: e61–e62.
 
23. Hwabejire JO, Saillant N, King R, et al. American College of Surgeons. Colonic paralytic ileus in COVID-19 patients. https://www.facs.org/for-medical-professionals/news-publications/journals/case-reviews/issues/v3n1/hwabejire-covid/. Published December 18, 2020. Accessed March 3, 2024.
 
24. Wicke C, Halliday B, Allen D, et al. Effects of steroids and retinoids on wound healing. Arch Surg 2000;135:1265–1270.
 
25. COVIDSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia 2021;77: 28–39.
 
26. Lee MO, Shim SB. Postoperative pulmonary complications in severe acute respiratory syndrome coronavirus 2 infected patients who underwent emergency surgery. Thorac Cancer 2023;14:2297–2301.
 
27. Evans T. Diagnosis and management of sepsis. Clin Med 2018;18:146–149.
 
28. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. Circulation 1996;93:2212–2245.
 
29. Heeney A, Hand F, Bates J, et al. Surgical mortality - an analysis of all deaths within a general surgical department. Surgeon 2014;12:121–128.
 
30. Magor R, Dabush-Elisha I, Aviram D, et al. In-hospital mortality of patients requiring unplanned postoperative ventilatory support: a multicenter observational study. Perioper Med 2022;11:44.
 
31. Dubois-Silva Á, Barbagelata-López C, Piñeiro-Parga P, et al. Deep vein thrombosis symptoms and 30-day mortality in acute pulmonary embolism. Eur J Intern Med 2023;108:43–51.